Privileged management of Afatinib oral therapy in clinical practice: outcome of the "all the difference" program

Authors

  • Jorge M. Freitas Departamento de Radioterapia do IPO-Porto, Porto

Keywords:

Oral therapeutic adhesion, Afatinib, Clinical guideline

Abstract

Nurses are in a unique position to empower patients in the effective management of therapeutic regimens. In 2017, Portuguese Association of Oncologic Nursing (AEOP) implemented an educational project called «All the Difference». The result was the definition of a guideline for implementing a nursing consultation in patients under Afatinib treatment.

Downloads

Download data is not yet available.

References

DiMatteo MR, (2004) “Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research”, Med Care. Mar; 42(3):200-9.

Garfield S, Eliasson L, Clifford S, Willson A, Barber N (2012) “Developing the Diagnostic Adherence to Medication Scale (the DAMS) for use in clinical practice”, BMC Health Services Research, 12:350.

Goodfellow N, Almomani B, Hawwa A, McElnay J (2013) “What the newspapers say about medication adherence: a content analysis”, BMC Public Health, 13:909.

Haynes, RB et al. (2008). Intervention for Enhancing Medication Adherence. The Cochrane Database of Systematic Reviews. Issue 2. [Consult. 7 Out. 2009] em http://www.sefap.it/servizi_letteraturacardio_200807/CD000011.pdf

Published

2018-06-20

How to Cite

1.
M. Freitas J. Privileged management of Afatinib oral therapy in clinical practice: outcome of the "all the difference" program. Onco.News [Internet]. 2018 Jun. 20 [cited 2024 Dec. 22];(36):6-9. Available from: https://onco.news/index.php/journal/article/view/70

Similar Articles

1 2 3 4 5 6 7 > >> 

You may also start an advanced similarity search for this article.